| Financial Year |
March 31 2023 |
| Monetary Funds |
195,898,051.03 |
| Held-for-trading Financial Assets |
300,000,000.00 |
| Notes Receivable |
1,600,000.00 |
| Accounts Receivable |
370,126,310.62 |
| Advances to Suppliers |
13,383,231.70 |
| Other Receivables |
8,378,563.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
48,735,660.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
56,726,706.41 |
| Total Current Assets |
1,650,085,331.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
15,577,527.82 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
852,464.27 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
12,269,753.89 |
| Deferred Income Tax Assets |
69,709,989.61 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
381,973,125.04 |
| Total Assets |
2,032,058,456.49 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
143,255,267.00 |
| Accounts Payable |
172,897,698.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,613,352.28 |
| Taxes Payable |
1,275,085.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,551,294.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,670,179.52 |
| Other Current Liabilities |
57,579,749.60 |
| Sub-Total of Current Liabilities |
485,188,805.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
126,887.44 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
35,770,918.86 |
| Total Liabilities |
520,959,724.02 |
| Paid-In Capital(Or Share Stock) |
150,359,930.00 |
| Capital Surplus |
1,026,906,185.18 |
| Surplus Reserve |
52,472,366.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
281,360,250.41 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,511,098,732.47 |
| Owner's Equity（Stockholder's Equity） |
1,511,098,732.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,032,058,456.49 |
